Class II · Moderate risk Terminated
vancomycin 1.5 g/500 mL added to 0.9% sodium chloride
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
FDA Drug Recalls
17,898 recalls, newest first
Class II · Moderate risk Terminated
vancomycin 1.5 g/250 mL added to 0.9% sodium chloride
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
PHENYLephrine 1
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
phenylephrine 50 mg added to 0.9% sodium chloride 250mL
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
PHENYLephrine
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
phenylephrine
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
PHENYLephrine 20mg/250ml added to 0.9% sodium chloride
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
PHENYLephrine
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
EPINEPHrine 8mg/250ml added to dextrose 5%
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
EPINEPHrine added to dextrose 5%
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
EPINEPHrine
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
Cardioplegia Solution del Nido Formula
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
vancomycin 1.25 g/250 mL added to 0.9% Sodium Chloride
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
EPINEPHrine 4mg/250mL added to 0.9% sodium chloride
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
dilTIAZem 125mg/125mL
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
glycopyrrolate 1 mg/5 mL
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
dilTIAZem 125mg/125mL
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
vancomycin 1.25 g/250 mL added to dextrose 5%
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
succinylcholine 200 mg/10 mL
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
vancomycin 1 g/250 mL added to 0.9% sodium chloride
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated
rocuronium50 mg/5 mL
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Ongoing
Testosterone Cypionate-Testosterone Propionate 180-20 mg/mL in cottonseed oil
Reason Lack of Assurance of Sterility
Class II · Moderate risk Terminated
Methylphenidate Hydrochloride Tablets
Reason Presence of Foreign Substance: Metal embedded in a tablet.
Class II · Moderate risk Ongoing
Oxacillin for Injection
Reason Lack of Assurance of Sterility
Class II · Moderate risk Ongoing
Oxacillin for Injection
Reason Lack of Assurance of Sterility